Effect of genotype and Previous GH treatment on adiposity in adults with prader-willi syndrome

Journal of Clinical Endocrinology and Metabolism

Volumn 101, Issue 12, 2016, Pages 4895-4903

  Coupaye, Muriel ^a   Tauber, Maithé ^c,d,e   Cuisset, Laurence ^f   Laurier, Virginie ^g   Bieth, Eric ^e   Lacorte, Jean Marc ^a   Oppert, Jean Michel ^a,b   Clément, Karine ^a,b   Poitou, Christine ^a,b  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^b SORBONNE UNIVERSITÉ   (France)

^c HÔPITAL DES ENFANTS   (France)

^d UNIVERSITÉ PAUL SABATIER   (France)

^e CHU PURPAN   (France)

^f ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

^g European Neuromuscular Center ENMC   (France)

Author keywords

[No Author keywords available]

Indexed keywords

GHRELIN; GROWTH HORMONE;

ADIPOCYTE; ADOLESCENT; ADULT; ARTICLE; BODY COMPOSITION; BODY FAT; BODY MASS; CONTROLLED STUDY; DUAL ENERGY X RAY ABSORPTIOMETRY; DYKENS HYPERPHAGIA QUESTIONNAIRE; FAT MASS; FEMALE; GENE DELETION; GENOTYPE; HUMAN; HYPERPHAGIA; MAJOR CLINICAL STUDY; MALE; METABOLIC PARAMETERS; OBESITY; PHENOTYPE; PRADER WILLI SYNDROME; PRIORITY JOURNAL; QUESTIONNAIRE; RESTING ENERGY EXPENDITURE; SUBCUTANEOUS FAT; UNIPARENTAL DISOMY; CHROMOSOME 15; CHROMOSOME DELETION; CLASSIFICATION; COHORT ANALYSIS; COMPARATIVE STUDY; GENETICS; METABOLISM; MIDDLE AGED; PHOTON ABSORPTIOMETRY; YOUNG ADULT;

ABSORPTIOMETRY, PHOTON; ADIPOCYTES; ADIPOSITY; ADOLESCENT; ADULT; BODY MASS INDEX; CHROMOSOME DELETION; CHROMOSOMES, HUMAN, PAIR 15; COHORT STUDIES; FEMALE; GENOTYPE; GROWTH HORMONE; HUMANS; MALE; MIDDLE AGED; PHENOTYPE; PRADER-WILLI SYNDROME; UNIPARENTAL DISOMY; YOUNG ADULT;

EID: 85003749591     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2016-2163     Document Type: Article

References (40)

1. Cassidy SB, Schwartz S, Miller JL, Driscoll DJ. Prader-Willi syndrome. Genet Med. 2012;14(1):10-26
2. Angulo MA, Butler MG, Cataletto ME. Prader-Willi syndrome: A review of clinical, genetic, and endocrine findings. J Endocrinol Invest. 2015;38(12):1249-1263
3. Webb T, Whittington J, Clarke D, Boer H, Butler J, Holland A. A study of the influence of different genotypes on the physical and behavioral phenotypes of children and adults ascertained clinically as having PWS. Clin Genet. 2002;62(4):273-281
4. Yang L, Zhan GD, Ding JJ, et al. Psychiatric illness and intellectual disability in the Prader-Willi syndrome with different molecular defects- A meta analysis. PLoS One. 2013;8(8):e72640
5. Gillessen-Kaesbach G, Robinson W, Lohmann D, et al. Genotypephenotype correlation in a series of 167 deletion and non-deletion patients with Prader-Willi syndrome.HumGenet. 1995;96(6):638-643
6. Cassidy SB, Forsythe M, Heeger S, et al. Comparison of phenotype between patients with Prader-Willi syndrome due to deletion 15q and uniparental disomy 15.AmJ Med Genet. 1997;68(4):433-440
7. Lin HY, Lin SP, Chuang CK, et al. Genotype and phenotype in patients with Prader-Willi syndrome in Taiwan. Acta Paediatr. 2007;96(6):902-905
8. Holsen LM, Zarcone JR, Chambers R, et al. Genetic subtype differences in neural circuitry of food motivation in Prader-Willi syndrome. Int J Obes (Lond). 2009;33:273-283
9. Lukoshe A, White T, Schmidt MN, van der Lugt A, Hokken-Koelega AC. Divergent structural brain abnormalities between different genetic subtypes of children with Prader-Willi syndrome. J Neurodev Disord. 2013;5(1):31
10. Galassetti P, Saetrum Opgaard O, Cassidy SB, Pontello A. Nutrient intake and body composition variables in Prader-Willi syndrome-effect of growth hormone supplementation and genetic subtype. J Pediatr Endocrinol Metab. 20(4)07;20:491-500
11. Khare M, Gold JA, Wencel M, et al. Effect of genetic subtypes and growth hormone treatment on bone mineral density in Prader-Willi syndrome. J Pediatr Endocrinol Metab. 2014;27(5-6):511-518
12. Kennedy L, Bittel DC, Kibiryeva N, Kalra SP, Torto R, Butler MG. Circulating adiponectin levels, body composition and obesity-related variables in Prader-Willi syndrome: Comparison with obese subjects. Int J Obes (Lond). 2006;30:382-387
13. Theodoro MF, Talebizadeh Z, Butler MG. Body composition and fatness patterns in Prader-Willi syndrome: Comparison with simple obesity. Obesity (Silver Spring). 2006;14(10):1685-1690
14. Laurier V, Lapeyrade A, Copet P, et al. Medical, psychological and social features in a large cohort of adults with Prader-Willi syndrome: Experience from a dedicated centre in France. J Intellect Disabil Res. 2015;59(5):411-421
15. Sode-Carlsen R, Farholt S, Rabben KF, et al. Body composition, endocrine and metabolic profiles in adults with Prader-Willi syndrome. Growth Horm IGF Res. 20(3)10;20:179-184
16. Lloret-Linares C, Faucher P, Coupaye M, et al. Comparison of body composition, basal metabolic rate and metabolic outcomes of adults with Prader Willi syndrome or lesional hypothalamic disease, with primary obesity. Int J Obes (Lond). 2013;37:1198-1203
17. Bedogni G, Grugni G, Tringali G, Marazzi N, Sartorio A. Does segmental body composition differ in women with Prader-Willi syndrome compared to women with essential obesity?. J Endocrinol Invest. 2015;38(9):957-961
18. Goldstone AP, Thomas EL, Brynes AE, et al. Visceral adipose tissue and metabolic complications of obesity are reduced in Prader-Willi syndrome female adults: Evidence for novel influences on body fat distribution. J Clin Endocrinol Metab. 2001;86(9):4330-4338
19. Talebizadeh Z, Butler MG. Insulin resistance and obesity-related factors in Prader-Willi syndrome: Comparison with obese subjects. Clin Genet. 2005;67(3):230-239
20. Marzullo P, Marcassa C, Minocci A, et al. Long-term echocardiographic and cardioscintigraphic effects of growth hormone treatment in adults with Prader-Willi syndrome. J Clin Endocrinol Metab. 2015;100(5):2106-2114
21. Lacroix D, Moutel S, Coupaye M, et al. Metabolic and adipose tissue signatures in adults with Prader-Willi syndrome: A model of extreme adiposity. J Clin Endocrinol Metab. 2015;100(3):850-859
22. Grugni G, Crinò A, Bedogni G, et al. Metabolic syndrome in adult patients with Prader-Willi syndrome. Nutr Metab Cardiovasc Dis. 2013;23(11):1134-1140
23. Purtell L, Viardot A, Sze L, et al. Postprandial metabolism in adults with Prader-Willi syndrome. Obesity (Silver Spring). 2015;23(6): 1159-1165
24. Coupaye M, Lorenzini F, Lloret-Linares C, et al. Growth hormone therapy for children and adolescents with Prader-Willi syndrome is associated with improved body composition and metabolic status in adulthood. J Clin Endocrinol Metab. 2013;98(2):E328-E335
25. Ferreira I, Snijder MB, Twisk JW, et al. Central fat mass versus peripheral fat and lean mass: Opposite (adverse versus favorable) associations with arterial stiffness?. The Amsterdam Growth and Health Longitudinal Study. J Clin Endocrinol Metab. 2004;89(6): 2632-2639
26. Coupaye M, Bouillot JL, Poitou C, Schutz Y, Basdevant A, Oppert JM. Is lean body mass decreased after obesity treatment by adjustable gastric banding?. Obes Surg. 2007;17(4):427-433
27. Ciangura C, Bouillot JL, Lloret-Linares C, et al. Dynamics of change in total and regional body composition after gastric bypass in obese patients. Obesity (Silver Spring). 2010;18(4):760-765
28. Müller MJ, Bosy-Westphal A, Krawczak M. Genetic studies of common types of obesity: A critique of the current use of phenotypes. Obes Rev. 2010;11(8):612-618
29. Cotillard A, Poitou C, Torcivia A, et al. Adipocyte size threshold matters: Link with risk of type 2 diabetes and improved insulin resistance after gastric bypass. J Clin Endocrinol Metab. 2014;99(8): E1466-E1470
30. Dykens EM, Maxwell MA, Pantino E, Kossler R, Roof E. Assessment of hyperphagia in Prader-Willi syndrome. Obesity (Silver Spring). 2007;15(7):1816-1826
31. Di Giorgio G, Grugni G, Fintini D, et al. Growth hormone response to standard provocative stimuli and combined tests in very young children with Prader-Willi syndrome. Horm Res Paediatr. 2014; 81(3):189-195
32. Oto Y, Obata K, Matsubara K, et al. Growth hormone secretion and its effect on height in pediatric patients with different genotypes of Prader-Willi syndrome. Am J Med Genet A. 2012;158A(6):1477-1480
33. Sales de Gauzy J, Gennero I, Delrous O, Salles JP, Lepage B, Accadbled F. Fasting total ghrelin levels are increased in patients with adolescent idiopathic scoliosis. Scoliosis. 2015;10:33
34. Feigerlová E, Diene G, Conte-Auriol F, et al. Hyperghrelinemia precedes obesity in Prader-Willi syndrome. J Clin Endocrinol Metab. 2008;93(7):2800-2805
35. Purtell L, Sze L, Loughnan G, et al. In adults with Prader-Willi syndrome, elevated ghrelin levels are more consistent with hyperphagia than high PYY and GLP-1 levels. Neuropeptides. 2011; 45(4):301-307
36. Kuppens RJ, Diène G, Bakker NE, et al. Elevated ratio of acylated to unacylated ghrelin in children and young adults with Prader-Willi syndrome. Endocrine. 2015;50(3):633-642
37. Kim SJ, Miller JL, Kuipers PJ, et al. Unique and atypical deletions in Prader-Willi syndrome reveal distinct phenotypes. Eur J Hum Genet. 20(3)12;20:283-290
38. Cadoudal T, Buléon M, Sengenès C, et al. Impairment of adipose tissue in Prader-Willi syndrome rescued by growth hormone treatment. Int J Obes (Lond). 2014;38:1234-1240
39. Odent T, Accadbled F, Koureas G, et al. Scoliosis in patients with Prader-Willi syndrome. Pediatrics. 2008;122(2):e499-e503
40. Chiche F, Le Guillou M, Chétrite G, et al. Antidepressant phenelzine alters differentiation of cultured human and mouse preadipocytes. Mol Pharmacol. 2009;75(5):1052-1061.